Search company, investor...

Triangle Pharmaceuticals


Acquired | Acquired

Total Raised




About Triangle Pharmaceuticals

Triangle Pharmaceuticals is an antiviral and anticancer drug development company.

Headquarters Location

4 University Place 4611 University Drive

Durham, North Carolina, 27707,

United States




Latest Triangle Pharmaceuticals News

Gilead Sciences Completes Acquisition of Triangle Pharmaceuticals

Jan 9, 2020

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 23, 2003--GileadSciences, Inc. (Nasdaq:GILD) announced today that it has completedits acquisition of Triangle Pharmaceuticals, Inc. (Nasdaq:VIRS) bymerging Triangle with a wholly owned subsidiary of Gilead. The mergerfollows a cash tender offer for all outstanding shares of Trianglecommon stock at $6.00 per share, which was completed at midnight, NewYork City time, on January 15, 2003. As a result of the merger, eachoutstanding share of Triangle not owned by Gilead, its subsidiaries orTriangle has been automatically converted into the right to receive$6.00 in cash, without interest, subject to appraisal rights. Trianglestockholders who did not tender their shares will receive a Notice ofMerger and a Letter of Transmittal that will instruct them as to howto receive the merger consideration. About Gilead Sciences Gilead Sciences is a biopharmaceutical company that discovers,develops and commercializes therapeutics to advance the care ofpatients suffering from life-threatening diseases worldwide. Thecompany has six marketed products and focuses its research andclinical programs on anti-infectives. Headquartered in Foster City,CA, Gilead has operations in the United States, Europe and Australia. For more information on Gilead, please call the Gilead PublicAffairs Department at 1-800-GILEAD-5 (1-800-445-3235) or --30--am/sf*

Triangle Pharmaceuticals Frequently Asked Questions (FAQ)

  • Where is Triangle Pharmaceuticals's headquarters?

    Triangle Pharmaceuticals's headquarters is located at 4 University Place, Durham.

  • What is Triangle Pharmaceuticals's latest funding round?

    Triangle Pharmaceuticals's latest funding round is Acquired.

  • How much did Triangle Pharmaceuticals raise?

    Triangle Pharmaceuticals raised a total of $155.66M.

  • Who are the investors of Triangle Pharmaceuticals?

    Investors of Triangle Pharmaceuticals include Gilead Sciences, Warburg Pincus, Point72 Asset Management, Merlin Biomed Group, QFinance and 11 more.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.